secwatch.observer — SEC 8-K summary
======================================

Issuer:     LIFECORE BIOMEDICAL, INC. DE (LFCR)
CIK:        0001005286
Form:       8-K
Filed at:   2022-11-07T23:59:59+00:00
Accession:  0001005286-22-000065
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Landec shareholders approve amendment to 2019 Stock Incentive Plan increasing share reserve by 759,797 shares
--------------------------------------------------------------------------------

- Shareholders elected Katrina L. Houde, Nelson Obus, and Jeffrey L. Edwards to the board with votes ranging from 15.2M to 17.7M for each.
- Amendment increases share reserve from 2,000,000 to 2,759,797 shares (759,797 new shares) and increases ISO limit to same total.
- Non-employee director annual award limit increased from $120,000 to $350,000 per fiscal year.
- Ratified Ernst & Young as independent auditor for fiscal year ending May 28, 2023 with 24.2M for, 9k against.
- Advisory vote on named executive officer compensation approved: 20.2M for, 1.1M against, 324k abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1005286/000100528622000065/0001005286-22-000065-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1005286/000100528622000065/lndc-20221101.htm
  HTML page:      https://secwatch.observer/filing/0001005286-22-000065

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer